Immune-Oncology Biomarkers of Response & Resistance

Utilizing Sonrai Discovery, we dive into the analysis of data from four melanoma immunotherapy clinical trials, focusing on 256 patients undergoing treatment with anti-PD-L1 or anti-CTLA-4 therapies. By integrating RNA Sequencing and Whole Exome Sequencing data, Sonrai Discovery quickly uncovers critical biomarkers that predict how patients will respond to treatment and identify potential resistance mechanisms. Sonrai Discovery offers a deeper understanding of tumor immune activity, paving the way for more personalized and effective cancer therapies.

Discover how Sonrai Cloud transformed our clients data analysis and reporting for their immunotherapy clinical trial. Click to explore the case study and learn more.

Do These Challenges Sound Familiar?

Contact our friendly team for expert guidance and transformative insights.

Discover how companies worldwide grow with Sonrai. Explore all our videos.

Jupyter Notebook and Sonrai Discovery

The integration of Jupyter Notebooks with Sonrai Discovery offers a streamlined and efficient method for transferring precision medicine data between code and no-code environments.

Weaver Plot

The Weaver Plot helps to gain a nuanced understanding of cancer-related gene expression across the body, aiding in identifying potential targets for effective cancer treatment.

Code-Optional Discovery

See how Sonrai Discovery seamlessly bridges the gap between technical and non-technical researchers in a code-optional environment.

Get in touch

Like What You See? Let's Talk

We Listen to your problems
We give you confidence to make your decision